Lynx1 Capital Management LP 13F Holdings

CIK 0001910456 · HUMACAO, PR

As of Sep 30, 2025, Lynx1 Capital Management LP reported 14 positions worth $491.3M in its SEC Form 13F filing.

Top 14 holdings

SecurityTickerSectorSharesValue% of portfolio
MERUS NVMRUSHealthcare1,534,141 44.4M29.40%
STOKE THERAPEUTICS INCSTOKHealthcare5,404,674 09.9M22.37%
GH RESEARCH PLCGHRSHealthcare8,601,189 04.3M21.23%
PROTAGONIST THERAPEUTICS INCPTGXHealthcare700,014$46.5M9.47%
CULLINAN THERAPEUTICS INCCGEMHealthcare5,766,090$34.2M6.96%
C4 THERAPEUTICS INCCCCCHealthcare7,098,133 5.8M3.21%
TSCAN THERAPEUTICS INCTCRXHealthcare7,857,347 4.3M2.91%
PRECISION BIOSCIENCES INCDTIL—1,042,596$5.8M1.17%
ADC THERAPEUTICS SAADCTHealthcare1,325,848$5.3M1.08%
Passage Bio IncPASGHealthcare623,704$5.0M1.02%
DENALI THERAPEUTICS INCDNLIHealthcare261,687$3.8M0.77%
IBIO INCIBIO—1,055,897$874.1K0.18%
ALLOGENE THERAPEUTICS INCALLOHealthcare546,119$677.2K0.14%
DESIGN THERAPEUTICS INCDSGNHealthcare65,954$496.6K0.10%